Brokerages have assigned a “Hold” rating to C4 Therapeutics, Inc. (NASDAQ:CCCC).
According to Bloomberg.com, the ten research firms monitoring C4 Therapeutics, Inc. (NASDAQ: CCCC) have collectively assigned the company a rating ...
Tag: CCCC, Analyst Rating
Analysts have issued a consensus recommendation of “Hold” on C4 Therapeutics, Inc. (NASDAQ:CCCC).
According to information made available by Bloomberg Ratings, the ten rating agencies that keep tabs on this particular company have ...
Analysts’ average recommendation for C4 Therapeutics, Inc. (NASDAQ:CCCC) is “Hold.”
The stock of C4 Therapeutics, Inc. (NASDAQ: C.C.C.C.), which ten different brokerages cover, has been given an average rating of ...
